Equity Investments

The Accelerator makes selective equity investments to support companies that are developing technologies with the potential to positively disrupt existing health solutions globally and especially at low cost in LMIC settings.

Select Filters

Domain

Subdomain

Investment Status

  • AI platform designing small RNAs

    Eleven Therapeutics

    Eleven Therapeutic

    Domain

    Subdomain

    Investment Status

  • AI-enabled platform for insect control

    Osmo Labs

    Domain

    Subdomain

    Investment Status

  • Breath biopsy platform for volatile detection

    Owlstone Medical

    Domain

    Subdomain

    Investment Status

  • Dendritic-cell-based mRNA vaccine for infectious diseases

    Transimmune

    Domain

    Subdomain

    Investment Status

  • In vivo gene therapy for sickle cell disease

    Ensoma

    Domain

    Subdomain

    Investment Status

  • Inhaled mRNA-based therapeutic for respiratory infections

    Ethris

    Domain

    Subdomain

    Investment Status

  • Inhaled mRNA-encoded antibodies for respiratory infections

    Tether Therapeutics

    Domain

    Subdomain

    Investment Status

  • Low-cost oral biologics

    Bactolife

    Domain

    Subdomain

    Investment Status

  • Nanobody-based platform to create novel vaccines

    Cerberus Therapeutics

    Domain

    Subdomain

    Investment Status

  • Next generation digital olfaction platform for disease detection

    Noze

    Domain

    Subdomain

    Investment Status